Icon

ZEMURON (nda020214)- (10MG/ML (10MG/ML),50MG/5ML (10MG/ML),100MG/10ML (10MG/ML))

ROCURONIUM BROMIDE ORGANON USA INC
10MG/ML (10MG/ML),50MG/5ML (10MG/ML),100MG/10ML (10MG/ML)
No No
2008-Oct-13 Expired
None None
None No
ZEMURON is a nondepolarizing neuromuscular blocking agent indicated as an adjunct to general anesthesia to facilitate both rapid sequence and routine tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation.
17 0 13
Total Other Developers None
Drugs with Suitability No
10MG/ML (10MG/ML) ** ** - - -
50MG/5ML (10MG/ML) ** ** - - 13
100MG/10ML (10MG/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
No 13
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******* *******, ***. *********** ******* *** *****, ***** *****, ***** ******** (**) *****, ****** ****** (***) ***
****** ******* ***** *** *.*. *** *********** ********** *, ***, ******, *********** (***) ***
****** ********* **** *** ********* **** ***, *** *********** **** ****** ****, ***** ******, *** **** (**) *****, ****** ****** (***) ***
****** ****** ******** ************ ****** ***. *********** *** *** *****-***** ******, ************, ** *** ***, ****** (***) ***
****** ***** ************* ***** ****** ******* *********** ****** **. *** - ***, *** & ***, **** ************* ***** *****, *. *. *****, ******** ****, ******** - ************* ******, ******* - ********** ********, *********, ********* ******, ***** (***) ***
****** **** **** ***** **** ***** ************ (********), *.* *********** ******* *** ** **, */**/**, ******** ******, ****-***, ******** (***) ***
****** ***** ****** *** ***** ****** ******* *********** ****** **. *** - ***, *** & ***, **** ************* ***** *****, *. *. *****, ******** ****, ******** - ************* ******, ******* - ********** ********, *********, ********* ******, ***** (***) ***
****** ***** ****** *** ***** ****** ******* *********** **** **: **-**, **, **, **-**, **. **. ***, ***, *** & ***, ***** ***, *****, ************ *******, ********** ******, ********** ********, *********, ********* ******, ***** (***) ***
****** ***** ****** *** ***** ********* ******* ******* *** *********** **** **. ** * & *, *** *****, ***** ********** ****, ***** ********, *****, ********* ******, ***** (***) ***
****** ***** ****** ***** ****** ************ ******* *********** ****-***, **** **: *, ** ** **, ***, ** ** **, ****, *****, ***, ************ *******, ********** ******, **********, ********* ******, ***** (***) ***
****** ******* ******** ******* **** ****** ** ******* ****** ******* ******* ********* *********** ******* ********* ******* ***** **:**, ********, ******* *****, ****** (***) ***
****** ******** *** ******** ****** ************** **., ***. *********** ******* ****, ******, ******** ******, ***** (***) ***
****** ****** ****** ******** ******* *********** ****** **.*** & ***. ******************, **************** (****), *********** (********), *************, ***** **** ******, ***** (***) ***
****** ******** ******* ****-****** *********** ************** **.,***. (*** ****) *********** **, ** ***** ****, ******* **** *** *** ********** *********** **** ******* ******, *******, ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.